Serum parathyroid hormone and phosphate influence the levels of circulating CD34+ cells in uremia

Journal of Nephrology

Volumn 23, Issue 6, 2010, Pages 693-698

  Lomonte, Carlo ^a   Derosa, Clorinda ^a   Vernaglione, Luigi ^b   Casucci, Francesco ^a   Losurdo, Nicola ^a   Libutti, Pasquale ^a   Teutonico, Annalisa ^a   Basile, Carlo ^a  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b Giannuzzi Hospital   (Italy)

Author keywords

CD34+ cell; Endothelial progenitor cell; Parathyroid hormone; Parathyroidectomy; Phosphate; Uremia

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CD34 ANTIGEN; CD45 ANTIGEN; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CELL COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; STEM CELL; UREA NITROGEN BLOOD LEVEL; UREMIA;

ADULT; AGED; ANTIGENS, CD34; CELL COUNT; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; STEM CELLS; UREMIA;

EID: 78549241293     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8:498-508. (Pubitemid 44145482)
2. Allegra A, Coppolino G, Bolignano D, et al. Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol. 2009;22:463-475.
3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606-1615. (Pubitemid 29297538)
4. Brunner S, Zaruba MM, Huber B, et al. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Exp Hematol. 2008;36:1157-1166.
5. Zaruba MM, Huber BC, Brunner S, et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res. 2008;77:722-731.
6. Napoli C, Williams-Ignarro S, Byrns R, et al. Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nature Clin Pract Cardiovasc Med. 2008;5:571-579.
7. KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009;76(Suppl 113):1-130.
8. Kazama JJ, Sato F, Omori K, et al. Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int. 2005;67:1120-1125.
9. Casino FG, Basile C, Gaudiano V, Lopez T. A modified algorithm of the single pool urea kinetic model. Nephrol Dial Transplant. 1990;5:214-219. (Pubitemid 20172150)
10. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-226.
11. de Groot K, Bahlmann FH, Sowa J, et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 2004;66:641-646. (Pubitemid 38982006)
12. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol. 2005;289:F679-684. (Pubitemid 41324188)
13. Bahlmann FH, de Groot K, Spandau JM, et al. Erithropoietin regulates endothelial progenitor cells. Blood. 2004;103:921-926.
14. Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol. 2004;15:S21-S24.
15. Blayney MJ, Pisoni RL, Bragg-Gresham JL, et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int. 2008;74:655-663.
16. Shantouf R, Kovesdy CP, Kim Y, et al. Association of serum alkaline phosphatase with coronay artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1106-1114.
17. Kalantar-Zadeh K, Kovesdy CP. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1529-1539.
18. Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66:2010-2016.
19. Tominaga Y, Matsuoka S, Uno N, Sato T. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial. 2008;12:S1-S6.
20. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208-2218.
21. Isakova T, Gutiérrez OM, Chang Y, et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009;20:388-396.